Upon the increased knowledge of breast cancer cells molecular pathways, the biological feature of gastric cancer is becoming more clear and particular attention should be paid to the identification of the human epidermal growth factor receptor-2 (HER2) amplified gastric cancer subtype. This evidence concerns the gene ERBB2 and breast cancer.